The announcement of a class action lawsuit against Maravai LifeSciences Holdings, Inc. is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The lawsuit alleges violations of federal securities laws, which can lead to financial penalties and damage to the company's reputation.